| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.everestorganicsltd.com | |
| Market Cap | 113.64 Cr. | |
| Enterprise Value(EV) | 151.77 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.43 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 99.42 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 29.84 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 58.50 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 2.43 | Calculated using Price: 142.05 |
| Dividend Yield | 1.06 | Period Ending 2021-03 |
| No. of Shares Subscribed | 0.80 Cr. | 8,000,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company's facilities comply to GMP standards and is certified by the Drug Control Authority of the Government of Andhra Pradesh, India. It supply products to major multinational companies abroad, prominent well established formulation companies in India, Europe, USA, Far East and the Middle East, and also to Latin / Central / South American Countries. The company also provides adequate technical & documentary support for their products and its products comply to various pharmacopial standards like BP, USP, EP and IP Standards as desired by the customer. | ||
| 1 Day |
|
+8.60% |
| 1 Week |
|
+8.44% |
| 1 Month |
|
-11.82% |
| 3 Month |
|
-21.78% |
| 6 Month |
|
-43.85% |
| 1 Year |
|
-58.31% |
| 2 Year |
|
-18.48% |
| 5 Year |
|
+36.19% |
| 10 Year |
|
| 9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 25.00 | 23.31 | 33.19 | 3.06 | 12.25 | 9.86 | 33.63 | 36.22 | 33.96 | |
| Return on Capital Employed (%) | 15.43 | 13.82 | 15.84 | 8.90 | 13.55 | 13.80 | 35.30 | 35.22 | 33.76 | |
| Return on Assets (%) | 1.35 | 1.42 | 2.50 | 0.25 | 1.67 | 1.90 | 7.45 | 9.58 | 10.73 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03* Rs. Cr. |
| Shh. Funds | 4 | 4 | 6 | 6 | 16 | 19 | 26 | 34 | 47 | 47 | |
| Non Curr. Liab. | 5 | 10 | 11 | 14 | 7 | 8 | 10 | 12 | 11 | 19 | |
| Curr. Liab. | 48 | 51 | 50 | 56 | 63 | 67 | 71 | 74 | 77 | 113 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 56 | 65 | 67 | 76 | 86 | 94 | 107 | 120 | 135 | 178 | |
| Non Curr. Assets | 24 | 25 | 25 | 29 | 37 | 36 | 40 | 41 | 46 | 60 | |
| Curr. Assets | 33 | 41 | 42 | 47 | 49 | 58 | 67 | 79 | 89 | 118 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 56 | 65 | 67 | 76 | 86 | 94 | 107 | 120 | 135 | 178 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. TTM |
| Net Sales | 80 | 96 | 106 | 99 | 107 | 112 | 156 | 167 | 182 | 200 | |
| Other Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |
| Total Income | 80 | 97 | 107 | 100 | 108 | 113 | 156 | 169 | 183 | 202 | |
| Total Expenditure | -74 | -91 | -98 | -94 | -101 | -105 | -138 | -148 | -159 | -194 | |
| PBIDT | 6 | 6 | 8 | 6 | 7 | 8 | 18 | 21 | 24 | 9 | |
| Interest | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | |
| Depreciation | -2 | -2 | -3 | -3 | -2 | -3 | -3 | -3 | -3 | -4 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | -1 | -5 | -3 | -4 | -1 | |
| Exceptional Items | -1 | -1 | |||||||||
| PAT | 1 | 1 | 2 | 0 | 1 | 2 | 8 | 11 | 14 | 1 | |
| Adjusted EPS | 1 | 1 | 2 | 1 | 2 | 2 | 9 | 14 | 17 | 1 |
| Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 6 | 7 | 1 | 4 | 7 | 10 | 5 | 9 | 10 | 14 | |
| Cash Fr. Inv. | -5 | -4 | -3 | -3 | -7 | -8 | -4 | -5 | -6 | -12 | |
| Cash Fr. Finan. | -2 | -3 | 2 | -2 | 0 | -2 | 0 | -3 | -3 | -2 | |
| Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | |
| Cash & Cash Eqvt | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
|
Thu, 09 Jun 2022
Announcement under Regulation 30 (LODR)-Credit Rating With reference to the captioned subject and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that based on ICRA update the Companys credit rating has been revised. |
|
Wed, 08 Jun 2022
Disclosure Of Related Party Transactions For Half Year Ended 31.03.2022 Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith disclosure on Related Party Transactions for the half year ended March 31 2022 in the requisite format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22 2021.This is for your information and records. |
|
Mon, 30 May 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication With reference to the audited financial results published on Financial Express (English Newspaper) and in Nava Telangana (Telugu Newspaper) dated 28.05.2022 and as submitted to the BSE on 28.05.2022 the signatory part was corrected from Managing Director to Chief Executive Officer and in Note No. 2 Audited Review Report was corrected as Auditors Report. The copy of corrigendum is enclosed herewith.Kindly take the above information on record. |
| Mon, 27 Jun 2022 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Close Crossing Last Week High
|
Opening at Low
|
Equities
M.F.
Sectors